Success Stories: EB-1A Approved for Postdoctoral Fellow in Texas in the Field of Pharmacology
Client’s Testimonial:
In view of my busy schedule, I could not have wished anything better that services offered by WeGreened.com! They are highly professional and swift in responding to all sorts of questions. I couldn't believe that I never required to call them till I heard about my I-140 approval from them! All my queries and concerns were answered through their secure web-messaging portal. This helped me immensely because each time I had a question, I would simply post it on their portal and in a short while they will get back to me with their answers and suggestions! I liked it very much as it saved lot of time. What impressed me the most is their punctuality in meeting deadlines as promised by them at various steps. Thank you so much WeGreened.com for all your help!
On January 15, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Postdoctoral Fellow in the Field of Pharmacology (Approval Notice)
Position at the Time of Case Filing: Postdoctoral Fellow
Country of Origin: India
Service Center: Texas Service Center (TSC)
Country of Residence at the Time of Filing: Texas
Approval Notice Date: January 15th, 2015
Processing Time: 2 Months, 10 Days (9 Days After Requesting Premium Processing)
For this case we worked with a pharmacologist from India with a specialized focus on neurobehavioral, metabolic, and endocrine disorders. His highly prolific career thus far had produced 11 peer-reviewed scientific articles and numerous presentations at national and international conferences, and he had been cited at least 191 times, primarily by independent researchers at prominent and leading institutions and organizations worldwide. This remarkable citation record clearly indicates the major significance of our client’s work. He had also reviewed at least 33 manuscripts for 20 or more distinctive, internationally-circulated journals. It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Pharmacology, and that his continued research would substantially and prospectively benefit the United States. An independent recommender affirmed the significance of our client’s research: “[Client] hypothesized that GLP-1 analogs might affect the anti-anxiety effect of alcohol and also buildup of tolerance to the effect and anxiety suffered during withdrawal. When he tested liraglutide and sitagliptin he found that both drugs increased the anti-anxiety effect and reduced the unwanted effects of tolerance and withdrawal. … [Client] has created a new and very appealing research strategy to oppose alcohol dependence, which arises naturally from the development of tolerance.” With the proof and documentation that we provided, his case was approved in two months and ten days.